Research Article
Quality and Brands of Amoxicillin Formulations in Nairobi, Kenya
Table 3
Uniformity of weight for amoxicillin capsule samples.
| | Sample code | Country of origin | Labelled active ingredients (mg) | | RSD | Mean weight deviation (%) | Number of capsules outside USP range | USP-acceptable criteria |
| | KAY52 | China | 250 | | 1.7 | -1.8862~3.1969 | 0 | ±7.5% | | SC10 | Kenya | 250 | | 2.9 | -5.2650~4.8147 | 0 | ±7.5% | | SB32 | India | 250 | | 2.0 | -4.0742~5.2004 | 0 | ±7.5% | | KAY56 | India | 500 | | 1.0 | -2.1520~1.9670 | 0 | ±5.0% | | KAY51 | India | 250 | | 3.2 | -8.2201~6.9579 | 1 | ±7.5% | | ZIM109 | Kenya | 250 | | 1.9 | -3.5171~4.1258 | 0 | ±7.5% | | CBD138 | Kenya | 250 | | 3.2 | -5.7932~4.8128 | 0 | ±7.5% | | KBR78 | China | 250 | | 2.6 | -3.2000~5.000 | 0 | ±7.5% | | KAN120 | United Kingdom | 500 | | 1.1 | -2.3955~1.9198 | 0 | ±5.0% | | SC13 | India | 500 | | 1.3 | -2.5349~2.2935 | 0 | ±5.0% | | SB21 | China | 500 | | 1.9 | -2.6478~4.0656 | 0 | ±5.0% | | KBR84 | Kenya | 500 | | 0.8 | -2.0788~1.1323 | 0 | ±5.0% | | KBR87 | India | 250 | | 2.2 | -4.8501~2.8629 | 0 | ±7.5% | | KBR67 | Kenya | 250 | | 2.3 | -5.0401~3.3219 | 0 | ±7.5% | | KRN94 | Mexico | 500 | | 1.3 | -0.0249~0.0189 | 0 | ±5.0% | | KBR77 | Kenya | 500 | | 1.4 | -2.3122~2.4810 | 0 | ±5.0% | | CBD128 | United Kingdom | 500 | | 1.0 | -1.3569~1.7639 | 0 | ±5.0% | | KAY42 | China | 500 | | 0.6 | -1.0115~1.3823 | 0 | ±5.0% | | SC12 | India | 500 | | 1.5 | -3.9329~2.9836 | 0 | ±5.0% | | KBR89 | India | 500 | | 4.1 | -10.496~4.2361 | 3 | ±5.0% | | CBD127 | China | 500 | | 4.0 | -6.822~9.0167 | 8 | ±5.0% | | KAN101 | India | 500 | | 5.4 | -8.6591~7.1950 | 9 | ±5.0% |
|
|
RSD: relative standard deviation; SD: standard deviation.
|
